AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

CervoMed Inc. Director's Dealing 2016

Feb 19, 2016

34364_dirs_2016-02-19_fab8f486-afe8-4bb7-a8b0-b6b48e5688d2.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Diffusion Pharmaceuticals Inc. (DFFN)
CIK: 0001053691
Period of Report: 2016-01-08

Reporting Person: Gilliam Richard Baxter (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Diffusion Pharmaceuticals Inc	12687975	Direct